abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL)

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class: Equity / Common Shares, $0.01 par value
Shares outstanding: 28.9M
Number of holders: 37
Total 13F shares, excl. options: 2.15M
Shares change: +2.07M
Total reported value, excl. options: $53.5M
Value change: +$51.5M
Number of buys: 34
Number of sells: -1
Price: $24.88

Significant Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q4 2014

37 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q4 2014.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2.15M shares of 28.9M outstanding shares and own 7.45% of the company stock.
Largest 10 shareholders include NEEDHAM INVESTMENT MANAGEMENT LLC (623K shares), MORGAN STANLEY (548K shares), WELLS FARGO & COMPANY/MN (279K shares), LPL Financial LLC (103K shares), CREDIT SUISSE AG/ (98.3K shares), UBS Group AG (79.9K shares), FIRST TRUST ADVISORS LP (63.9K shares), OPPENHEIMER & CO INC (45.5K shares), GUGGENHEIM CAPITAL LLC (33.9K shares), and AMERICAN INTERNATIONAL GROUP INC (33.4K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.